Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO_ART: Omalizumab for Pregnancy Rate in Asthmatic Women
NCT03727971Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Jan 2019
- Primary completion
- Dec 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of omalizumab in infertility, sponsored by Rigshospitalet. Started Jan 2019; status: completed.
02
Drugs
omalizumab
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03727971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03727971.